[1]杨 敏,汤云昭,倪长林.2型糖尿病患者心血管疾病的发病机制[J].医学信息,2020,33(06):56-58.[doi:10.3969/j.issn.1006-1959.2020.06.017]
　YANG Min,TANG Yun-zhao,NI Chang-lin.The Pathogenesis of Cardiovascular Disease in Patients with Type 2 Diabetes[J].Medical Information,2020,33(06):56-58.[doi:10.3969/j.issn.1006-1959.2020.06.017]
点击复制

2型糖尿病患者心血管疾病的发病机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年06期
页码:
56-58
栏目:
综述
出版日期:
2020-03-15

文章信息/Info

Title:
The Pathogenesis of Cardiovascular Disease in Patients with Type 2 Diabetes
文章编号:
1006-1959（2020）06-0056-03
作者:
杨 敏; 汤云昭; 倪长林
（天津医科大学朱宪彝纪念医院心血管内科/国家卫生健康委员会激素与发育重点实验室/天津市代谢性疾病重点实验室/天津市内分泌研究所，天津 300134）
Author(s):
YANG Min; TANG Yun-zhao; NI Chang-lin
(Department of Cardiovascular Medicine,Zhu Xianyi Memorial Hospital,Tianjin Medical University/Key Laboratory of Hormones and Development of National Health Committee/Tianjin Key Laboratory of Metabolic Diseases/Tianjin Institute of Endocrinology,Tianjin 300134,China)
关键词:
2型糖尿病; 心血管疾病; 发病机制
Keywords:
Type 2 diabetes; Cardiovascular disease; Pathogenesis
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2020.06.017
文献标志码:
A
摘要:
2型糖尿病是常见的一种内分泌代谢疾病，是心肌梗死、卒中等各种心血管疾病发生发展的主要危险因素。探讨2型糖尿病患者心血管疾病发病机制对预防和治疗2型糖尿病患者心血管疾病具有重要的指导作用，目前关于该病的发病机制尚不完全清楚。研究显示，高血糖、高胰岛素血症、血管内皮功能受损、炎症反应、脂肪细胞因子、动脉粥样硬化血脂异常等因素均可能参与糖尿病心血管疾病的发生发展，本文就2型糖尿病患者心血管疾病发病机制相关研究进行综述。
Abstract:
Type 2 diabetes is a common endocrine and metabolic disease and a major risk factor for the development of various cardiovascular diseases such as myocardial infarction and stroke. To explore the pathogenesis of cardiovascular disease in patients with type 2 diabetes has an important guiding role in the prevention and treatment of cardiovascular disease in patients with type 2 diabetes. At present, the pathogenesis of this disease is not completely clear. Studies show that factors such as hyperglycemia, hyperinsulinemia, impaired vascular endothelial function, inflammatory response, adipocytokines, and atherosclerotic dyslipidemia may be involved in the development of cardiovascular disease in diabetes; this article reviews the research on the pathogenesis of cardiovascular disease in patients with type 2 diabetes.

参考文献/References:

[1]刘紫庭,李雨捷,赵伟,等.NOX在糖尿病肾病发病机制中的作用[J].广东医学,2016,37(19):2984-2986.[2]刘晓燕,杨彬婕,何晓健,等.心血管疾病风险与食物血糖指数和血糖负荷相关性分析[J].中国医学前沿杂志电子版,2015,7(6):83-85.[3]陈泽洁,李二凤,钟池.抑郁症发病机制及与甲状腺功能的关系[J].神经疾病与精神卫生,2015,15(1):100-102.[4]Cho NH,Shaw JE,Karuranga S,et al.IDF diabetes atlas: Global estimatesof diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018(138):271-281.[5]曹岩,姚岚,方芳.糖尿病性冠心病中医治则研究与病机分析[J].现代中西医结合杂志,2015,24(19):2160-2163.[6]刘东慧,颜勇,刘美晓,等.2型糖尿病与非酒精性脂肪性肝病[J].承德医学院学报,2017,34(1):57-59.[7]刘艳华.2型糖尿病对心血管疾病的影响因素分析[J].糖尿病新世界,2015,13(10):218.[8]陆菊明.糖尿病心血管病变的防治:路在何方[J].中国糖尿病杂志,2016,8(3):129-131.[9]Wan A,Rodrigues B.Endothelial cell-cardiomyocyte crosstalk indiabetic cardiomyopathy[J].Cardiovasc Res,2016,11(3):172-183.[10]Bugger H,Abel ED.Molecular mechanisms of diabetic cardiomyopathy[J].Diabetologia,2014, 57(4):660-671.[11]Jia G,DeMarco VG,Sowers JR.Insulin resistance and hyperinsulinaemiain diabetic cardiomyopathy[J].Nat Ｒev Endocrinol,2016,12(3):144-153.[12]陈铭林,吴铿.TGF-β1对糖尿病心肌病的影响[J].临床医学工程,2014,21(2):260-261,264.[13]Kovacic JC,Castellano JM,Farkouh ME,et al.The relationshipsbetween cardiovascular disease and diabetes: Focus on pathogenesis[J].Endocrinol Metab Clin North Am,2014,43(1):41-57.[14]李萌,吕仕超,吴美芳,等.不同原因诱导的心肌纤维化动物模型的建立[J].医学研究生学报,2014,27(3):330-334.[15]张翠,张根葆,朱海龙.银杏总黄酮对糖尿病大鼠心肌转化生长因子β1表达的影响[J].中国老年学杂志,2014,32(16):3467-3469.[16]吕小萍,邰杨芳,石晓敬.国内心血管疾病研究热点探析-基于共词聚类分析方法[J].山西医科大学学报,2016,47(2):119-123.[17]刘欢.糖尿病患者心血管疾病发病机制的研究[J].心血管病防治知识(学术版),2017(6):139-140.[18]田东华,王永红,季康.2型糖尿病患者HbAlc水平与心房颤动的关系[J].中国医刊,2014,47(8):45.[19]杨伟,李耘,华琦.老年糖尿病和心血管疾病的研究[J].中华老年心脑血管病杂志,2017,19(4):431-433.[20]杨雪.二肽基肽酶4抑制剂与心血管疾病相关性的研究[J].中国心血管病研究,2015,13(2):121-125.[21]Banerjee PS,Ma J,Hart GW.Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria[J].Proc Natl AcadSci U S A,2015,112(19):6050-6055.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(06):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(06):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]郭俊林,张 立.基质金属蛋白酶-2与冠状动脉粥样硬化性疾病的研究进展[J].医学信息,2018,31(04):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
　GUO Jun-lin,ZHANG Li.Progress of the Researchon Matrix Metalloproteinase-2 and Coronary Atherosclerotic Disease[J].Medical Information,2018,31(06):27.[doi:10.3969/j.issn.1006-1959.2018.04.010]
[4]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(06):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[5]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(06):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[6]张 慧,黄艳群,王 妮,等.基于美国全国住院病人样本的心血管疾病研究进展[J].医学信息,2018,31(07):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
　ZHANG Hui,HUANG Yan-qun,WANG Ni,et al.Research Progress of Cardiovascular Disease Based on National Inpatient Sample[J].Medical Information,2018,31(06):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
[7]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(06):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[8]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(06):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[9]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Medical Information,2022,35(06):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[10]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
　PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Medical Information,2022,35(06):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[11]刘瑞芳,赵 华,史红娟,等.益生菌与2型糖尿病心血管疾病的研究进展[J].医学信息,2019,32(18):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
　LIU Rui-fang,ZHAO Hua,SHI Hong-juan,et al.Advances in Research on Probiotics and Cardiovascular Diseases in Type 2 Diabetes[J].Medical Information,2019,32(06):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]

更新日期/Last Update: 2020-03-15